DE60042056D1 - Menschliche Carnosinase 2 - Google Patents

Menschliche Carnosinase 2

Info

Publication number
DE60042056D1
DE60042056D1 DE60042056T DE60042056T DE60042056D1 DE 60042056 D1 DE60042056 D1 DE 60042056D1 DE 60042056 T DE60042056 T DE 60042056T DE 60042056 T DE60042056 T DE 60042056T DE 60042056 D1 DE60042056 D1 DE 60042056D1
Authority
DE
Germany
Prior art keywords
carnosinase
human
polypeptides
polynucleotides
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60042056T
Other languages
English (en)
Inventor
Jean-Pierre Ledig
Vladimir Saudek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Application granted granted Critical
Publication of DE60042056D1 publication Critical patent/DE60042056D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60042056T 2000-02-04 2000-02-04 Menschliche Carnosinase 2 Expired - Lifetime DE60042056D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00400313A EP1122307B1 (de) 2000-02-04 2000-02-04 Menschliche Carnosinase 2

Publications (1)

Publication Number Publication Date
DE60042056D1 true DE60042056D1 (de) 2009-06-04

Family

ID=8173533

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60042056T Expired - Lifetime DE60042056D1 (de) 2000-02-04 2000-02-04 Menschliche Carnosinase 2

Country Status (4)

Country Link
EP (1) EP1122307B1 (de)
AT (1) ATE429489T1 (de)
DE (1) DE60042056D1 (de)
DK (1) DK1122307T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002218160A1 (en) * 2000-09-11 2002-03-22 Bayer Aktiengesellschaft Regulation of human carboxypeptidase-like enzyme
WO2005064013A1 (en) * 2003-12-23 2005-07-14 Bart Janssen The use of carnosine metabolism-associated genes to determine genetic predisposition/susceptibility to diabetic nephropathy
DE10360956A1 (de) * 2003-12-23 2005-07-28 Ruprecht-Karls-Universität Heidelberg System und Verfahren zum Nachweis von diabetischer Nephropatie oder einer Prädisposition dafür

Also Published As

Publication number Publication date
EP1122307B1 (de) 2009-04-22
EP1122307A1 (de) 2001-08-08
DK1122307T3 (da) 2009-08-17
ATE429489T1 (de) 2009-05-15

Similar Documents

Publication Publication Date Title
WO1998031799A3 (en) Polynucleotides and polypeptides encoding receptors
DK1961767T3 (da) Diagnose og behandling af cancere og andre lidelser
AU7494701A (en) Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
EP1001023A3 (de) Frizzled-4, ein möglicher Wnt-Rezeptor
DK1078063T3 (da) BASB029-polynukleotider og -polypeptider fra Neisseria meningitidis
DE69942803D1 (de) Rotein änhelt, und dafür kodierende cdns
NO20000731D0 (no) Neisseria-lactodweeinbindingsprotein
DE60042056D1 (de) Menschliche Carnosinase 2
EP0885959A3 (de) Menschlisches Wnt-5b Protein
EP0943684A3 (de) Frizzled-ähnliche Polypeptide und Polynukleotide
DE60036469D1 (de) 17867, eine menschliche aminopeptidase
EP0887416A3 (de) Menschliches AFC1 Enzym
ATE281524T1 (de) Moraxella catarrhalis pilq proteine
EP0887415A3 (de) Menschliches RCE1
WO2001043759A3 (en) Use of 11cby popypeptides and polynuceotides
DE60134253D1 (de) Basb205 polypeptide und dafür kodierende polynukleotide
WO2001085921A3 (en) Human serine-threonine kinase-4
WO2001068816A8 (en) Human histamine h3 gene variant-3
DK1309690T3 (da) MFQ-111, et humant GTPase-lignende protein
EP0897009A3 (de) HKABY60 Polypeptide
WO1998042833A3 (en) Kv potassium channel polypeptides and polynucleotides
Hong et al. Cost-effective Isotope-labeling Technique Developed for $^{15} N/^{13} C $-labeled Novel Human Protein Tyrosine Kinas6 (PTK6)
WO2002002780A3 (en) Human serine-threonine kinase
EP0897986A3 (de) Aspartat proteinase 5 (ASP5)
WO2001077148A3 (en) Human lipid binding protein 1

Legal Events

Date Code Title Description
8364 No opposition during term of opposition